Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00133029 · ClinicalTrials.gov registry record · Phase 4

The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity

A Phase 4 study, sponsored by University of Pennsylvania.

Terminated
Registry status
Phase 4
Development phase

NCT00133029: Clinical Trial Phase 4 study, sponsored by University of Pennsylvania.

NCT00133029 is a Phase 4 study that was terminated before completion, run by University of Pennsylvania. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00133029, a Phase 4 study, was terminated before completion, sponsored by University of Pennsylvania.

TERMINATED
Registry status
Phase 4
Development phase

Study Summary

The purpose of this study is to determine whether the timing of prophylactic antibiotic administration for cesarean section (immediate preoperative versus intraoperative administration) impacts the rate of postoperative febrile morbidity. The specific aim of the project is to test the hypothesis that preoperative antibiotic administration will decrease the rate of composite postoperative febrile morbidity.

Interventions

  • DRUG Timing of prophylactic antibiotic administration

Trial Details

FieldValue
Start Date 2004-07
Est. Completion 2006-07
Phase Phase 4
University of Pennsylvania

1,423 total trials

Why NCT00133029 stopped before completion

NCT00133029 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which Timing of prophylactic antibiotic administration is the first listed.

NCT00133029 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00133029 about?

NCT00133029 is a clinical study titled "The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity". The purpose of this study is to determine whether the timing of prophylactic antibiotic administration for cesarean section (immediate preoperative versus intraoperative administration) impacts the rate of postoperative febrile morbidity. The specific aim of the project is to test the hypothesis tha...

What is the current status of trial NCT00133029?

This trial is currently terminated. It is a Phase 4 study. The study started on 2004-07. Estimated completion is 2006-07.

What interventions are being tested in trial NCT00133029?

The interventions under investigation include: Timing of prophylactic antibiotic administration (DRUG).

Who is sponsoring clinical trial NCT00133029?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00133029, the US trial registry maintained by the National Library of Medicine. NCT00133029 (unsized enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.